ATRi enhanced radiotherapy-induced inflammation in the TME with NK cells playing a central role in maximizing treatment efficacy. Anti-tumour activity of NK cells can be further boosted with ICI targeting TIGIT and PD-1. This evidence concerns the gene TIGIT and neoplasm.